A pair of drugmakers priced their initial public offerings on Thursday, delivering the best month for US health care ...

The companies raised prices a median 4%, though some drugs will cost thousands of dollars more.

Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...

Drugmakers have raised the list prices of more than 800 prescription drugs — ranging from blood pressure medications to cancer treatments — by a median of 4% at the start of this year, The Wall Street ...

Robert F. Kennedy Jr. said that if he is confirmed he will not collect fees from litigation against the drugmakers of a ...

The Tax Cuts and Jobs Act of 2017 reconfigured the tax code. Did it also enable a pharmaceutical giant to invest in Wake ...

The Trump administration’s Centers for Medicare & Medicaid Services (CMS) has signaled that it will be revamping the process ...

Sage Therapeutics has rejected the unsolicited acquisition offer it received earlier this month from longtime partner Biogen ...

Health-care companies fell, but not by as much as the broad market, amid a generally strong round of earnings from drugmakers. AbbVie shares rose after the pharmaceutical company reported ...

It’s the latest step from pharmacy benefit managers to respond to relentless criticism from politicians and regulators over ...

Drugmakers raised the list prices of more than 800 prescription drugs for blood pressure, cancer and other conditions by a median 4% at the start of this year. The modest size of the annual ...